Close

Corbus Pharmaceuticals (CRBP) PT Raised to $27 at JMP Securities

March 30, 2017 3:58 PM EDT Send to a Friend
JMP Securities raised its price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $27.00 (from $20.00) while maintaining a Market Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login